THE SUBJECT EXPERT COMMITTEE

How SEC changed Covaxin stance

At the Jan 2 meeting, the firm presented more data and notably “requested for consideration of their proposal in the wake of incidence of n...

Experts raise concerns over approval to Covid-19 vaccines

A number of medical experts and public health activists have raised concerns over grant of emergency approval to Covid-19 vaccines of Bhara...

DCGI approves SII's Covishield and Bharat Biotech's Covaxin for restrictive use in emergency situation

The subject expert committee had given conditional nod to both the vaccines and these were awaiting the drug regulator's approval.

Bharat Biotech's Covaxin gets Subject Expert Committee (SEC) approval for emergency use

A day after the Subject Expert Committee gave a go-ahead to SII, Oxford-Astrazeneca vaccine candidate-Covishield, the expert panel today re...

Covid-19 vaccine will be available in Uttar Pradesh near Makar Sankranti: Yogi Adityanath

Vaccination drive in Uttar Pradesh will begin around Makar Sankranti, CM Adityanath said on Saturday, a day after the Serum Institute of In...

Maharashtra: COVID-19 vaccine dry run carried out in four districts

Specific teams were formed for various tasks by the district administrations and activities like uploading of dummy beneficiary data, sessi...

No approval for Covaxin, expert panel seeks more data from Bharat Biotech

Earlier on Friday, the expert committee, which is tasked with vetting covid-19 vaccine proposals, recommended emergency licensure for the S...

SEC to reconvene on January 1 to consider emergency use authorisation for COVID-19 vaccines

​​​​​​The subject expert committee on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on December 9 had sought addition...

Serum's chances for Covishield nod rise after UK regulator approves Oxford COVID-19 vaccine

The SEC was called soon after the UK regulator authorised Oxford University/AstraZeneca’s Covid-19 vaccine for use. The approval by UK regu...

Oxford COVID-19 vaccine may become the first to get Indian regulator's nod for emergency use

Serum Institute of India (SII) last week also had submitted some additional data required by the Drug Controller General of India (DCGI), t...

India in touch with UK drug officials on Oxford Covid-19 vaccine: Vaccine Task Force Committee

“India’s drug regulator is in touch with UK drug authorities on the approval progress of the AZ/Oxford vaccine trial,” Vinod Paul, head of ...

Our COVID-19 vaccine is safe, developed on proven technology, says Bharat Biotech Chairman

Bharat Biotech has applied to the drug regulator seeking market authorisation for its potential Covid-19 vaccine-Covaxin which is being dev...

Covid Vaccine: Expert committee seeks more data from Serum Institute, Bharat Biotech for approval

The 10-member panel said SII should submit the outcome of the assessment of AstraZeneca-Oxford University trials done by the UK drug regula...

Experts to consider Pfizer’s India application this week

“The matter has been referred to the Subject Expert Committee (SEC), the panel that advises the Drug Controller General of India on new dru...

SC says Nov 9 e-auction of 34 coal blocks will be subject to its orders

A bench of Chief Justice S A Bobde and Justices A S Bopanna and V Ramasubramanian asked the Centre to inform the bidders that benefits of a...

Eli Lilly receives permission to conduct Phase 3 clinical trials for Covid treatment

The Subject Expert Committee (SEC) that advises the drug regulatory authority on new drugs, vaccines for Covid gave its permission to the c...

Drug regulator approves Hyderabad-based Biological E's phase I/II trials of Covid vaccine

Biological E has tied up with an undisclosed company and will be conducting the trials. The announcement about the tie up is likely to be m...